生物材料市場 - 分產品（金屬、聚合物、陶瓷、天然）、按應用（心血管、骨科、牙科、整形外科、眼科、傷口癒合、神經病學、組織工程）及預測，2023 - 2032

Biomaterials Market - By Product (Metallic, Polymeric, Ceramic, Natural), By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Ophthalmology, Wound Healing, Neurology, Tissue Engineering) & Forecast, 2023 - 2032

出版日期: 2023年08月31日 | 出版商:

Global Market Insights Inc. | 英文 485 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年至 2032 年間，全球生物材料市場年複合成長率將超過 12.6%。有前途的新創公司和創新品牌不斷增加的投資正在推動市場成長。例如，2023 年 10 月，專門從事生物材料的新創公司 GOZEN 獲得了 330 萬美元的種子資金，該公司有望徹底改變時尚、汽車和家居產業。本輪融資由 Happiness Capital 牽頭，將使 GOZEN 能夠加快其創新生物材料 LUNAFORM (TM) 的研究、開發和規模化計畫。此外，它將提供開創新型先進材料創造所需的資源。

這些新進入者正在為該行業注入新穎的想法和突破性的技術。這種創造力和資本的注入正在推動尖端生物材料的發展。因此，隨著該行業不斷發展以滿足醫療保健、製造等各個行業的需求，生物材料市場前景必將增強。

整個生物材料市場根據產品、應用和地區進行分類。

高分子生物材料領域將在 2023 年至 2032 年間經歷重大發展。這些多功能材料在從植入物到藥物傳輸系統的各種醫療應用中發揮關鍵作用。它們的生物相容性、可調特性和低免疫原性使它們對醫療和保健行業越來越有吸引力。隨著聚合物生物材料研究和開發的進步，該領域的生物材料市場規模將繼續其成長軌跡。

2023年至2032年，眼科領域的年複合成長率將顯著。這一成長歸因於用於人工晶狀體、角膜植入物和藥物輸送系統的先進生物材料的開發。眼科生物材料因其生物相容性和更精確地解決視覺相關問題的能力而受到追捧。隨著眼睛健康的重要性日益增加，眼科生物材料市場需求也隨之增加。

2023年至2032年，歐洲生物材料市場將呈現可觀的年複合成長率。對生物可分解聚合物、組織工程支架和生物活性陶瓷等生物材料的需求正在上升。歐洲對環保解決方案和醫療技術進步的堅定承諾正在推動生物材料在從醫療設備到再生醫學等多種應用中的採用，使該地區成為該市場的關鍵參與者。例如，2023 年 10 月，專門開發源自倫敦海藻的生物塑膠材料的藍色生物技術公司 FlexSea 在種子輪融資中成功獲得 230 萬歐元的股權融資。

產業生態系統分析
產業影響力
- 成長動力
  - 醫療應用對生物相容性和可生物分解材料的需求不斷增加
  - 組織工程日益普及
  - 奈米技術和組織工程的進展
  - 政府推動生物材料產品使用的舉措
- 產業陷阱與挑戰
  - 生物材料開發成本高
  - 生物相容性和安全問題
成長潛力分析
COVID-19 影響分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：生物材料市場規模與預測：依產品分類，2018 - 2032

主要動向：按產品
金屬生物材料
- 鈦及鈦合金
- 不銹鋼
- 銀
- 鈷鉻合金
- 金子
- 鎂
高分子生物材料
- 聚酯纖維
- 矽橡膠
- 聚乙烯
- 聚甲基丙烯酸甲酯
- 聚醚醚酮
- 尼龍
- 其他高分子生物材料
陶瓷生物材料
- 磷酸鈣
- 氧化鋯
- 硫酸鈣
- 碳
- 氧化鋁
- 玻璃
天然生物材料
- 玻尿酸
- 膠原
- 絲綢
- 海藻酸鹽
- 纖維蛋白
- 明膠
- 纖維素
- 甲殼質

第 6 章：生物材料市場規模與預測：按應用，2018 - 2032

主要動向：按應用
心血管
- 植入式心臟去顫器
- 起搏器
- 支架
- 血管移植物
- 感應器
- 導絲
- 其他心血管應用
眼科
- 隱形眼鏡
- 人工水晶體
- 眼組織置換
- 人工角膜
- 其他眼科應用
牙科
- 植牙
- 組織再生材料
- 骨移植和替代品
- 牙膜
- 其他牙科應用
骨科
- 關節置換生物材料
- 骨科生物製劑
- 生物可吸收組織固定產品
- 黏性補充
- 脊椎生物材料
- 其他骨科應用
傷口癒合
- 骨折癒合裝置
- 黏附屏障
- 皮膚替代品
- 內部組織密封劑
- 手術止血鉗
- 其他傷口癒合應用
整型手術
- 軟組織填充劑
- 臉部皺紋治療
- 顱顏手術
- 生物工程皮膚
- 週邊神經修復
- 無細胞真皮基質
- 其他整形外科應用
神經病學
- 神經幹細胞封裝
- 調車系統
- 用於中樞神經系統修復的水凝膠支架
- 皮質神經假體
- 其他神經學應用
組織工程
其他應用

第 7 章：生物材料市場規模與預測：按地區分類，2018 - 2032

主要動向：按地區
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區

第 8 章：公司簡介

BASF SE
Covestro AG
ROYAL DSM
Celanese Corporation
Carpenter Technology Corporation
Corbion
EVONIK INDUSTRIES
Berkeley Advanced Biomaterials
CAM Bioceramics B.V.
CeramTec GmbH
Noble Biomaterials
Victrex plc.
Mitsubishi Chemical Group Corporation.
CoorsTek Inc.
Zeus Company Inc.

簡介目錄

Product Code: 6603

Global Biomaterials Market will witness over 12.6% CAGR between 2023 and 2032. Increasing investments from promising startups and innovative brands are leading to market growth. For instance, in October 2023, GOZEN, a startup specializing in biomaterials poised to revolutionize the fashion, automotive, and home furnishings sectors, secured $3.3 million in seed funding. This funding round, spearheaded by Happiness Capital, will empower GOZEN to expedite its research, development, and scaling initiatives for its innovative biomaterial, LUNAFORM™. Additionally, it will provide the resources needed to pioneer the creation of new, advanced materials.

These fresh entrants are infusing the industry with novel ideas and groundbreaking technologies. This injection of creativity and capital is driving the development of cutting-edge biomaterials. Therefore, as the industry evolves to meet the demands of various sectors, including healthcare, manufacturing, and beyond, the biomaterials market outlook is set to strengthen.

The overall Biomaterials Market is classified based on product, application, and region.

Polymeric biomaterials segment will undergo significant development from 2023 to 2032. These versatile materials play a pivotal role in various medical applications, from implants to drug delivery systems. Their biocompatibility, tunable properties, and low immunogenicity make them increasingly attractive to medical and healthcare industries. As research and development in polymeric biomaterials advance, the biomaterials market size from this segment is set to continue its growth trajectory.

Ophthalmology segment will register a notable CAGR from 2023 to 2032. This surge is attributed to the development of advanced biomaterials for intraocular lenses, corneal implants, and drug delivery systems. Ophthalmic biomaterials are sought after for their biocompatibility and ability to address vision-related issues with greater precision. As the importance of eye health grows, so does the biomaterials market demand in ophthalmology.

Europe biomaterials market will showcase an appreciable CAGR from 2023 to 2032. Demand for biomaterials, such as biodegradable polymers, tissue engineering scaffolds, and bioactive ceramics, is on the rise. Europe's strong commitment to eco-friendly solutions and advancements in medical technologies is driving the adoption of biomaterials across diverse applications, from medical devices to regenerative medicine, positioning the region as a key player in this market. For instance, in October 2023, FlexSea, a blue biotech firm specializing in the development of bioplastic materials derived from seaweed originating from London, successfully secured €2.3 million in equity funding during its seed round.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis
1.5 Data validation
1.6 Data Sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Biomaterials industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Product trends
- 2.1.4 Application trends

Chapter 3 Biomaterials Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing demand for biocompatible and biodegradable materials in medical applications
  - 3.2.1.2 Growing popularity of tissue engineering
  - 3.2.1.3 Advances in nanotechnology and tissue engineering
  - 3.2.1.4 Government initiatives to promote the use of biomaterial products
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High development cost for biomaterials
  - 3.2.2.2 Biocompatibility and safety concerns
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By application
3.4 COVID- 19 impact analysis
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategy dashboard, 2022

Chapter 5 Biomaterials Market Size and Forecast, By Product, 2018 - 2032 (USD Million)

5.1 Key trends, by product
5.2 Metallic biomaterials
- 5.2.1 Titanium & titanium alloys
- 5.2.2 Stainless steel
- 5.2.3 Silver
- 5.2.4 Cobalt-chrome alloys
- 5.2.5 Gold
- 5.2.6 Magnesium
5.3 Polymeric biomaterials
- 5.3.1 Polyester
- 5.3.2 Silicone rubber
- 5.3.3 Polyethylene
- 5.3.4 Polymethymethacrylate
- 5.3.5 Polyetheretherketone
- 5.3.6 Nylon
- 5.3.7 Other polymeric biomaterials
5.4 Ceramic biomaterials
- 5.4.1 Calcium phosphate
- 5.4.2 Zirconia
- 5.4.3 Calcium sulfate
- 5.4.4 Carbon
- 5.4.5 Aluminium oxide
- 5.4.6 Glass
5.5 Natural biomaterials
- 5.5.1 Hyaluronic acid
- 5.5.2 Collagen
- 5.5.3 Silk
- 5.5.4 Alginates
- 5.5.5 Fibrin
- 5.5.6 Gelatin
- 5.5.7 Cellulose
- 5.5.8 Chitin

Chapter 6 Biomaterials Market Size and Forecast, By Application, 2018 - 2032 (USD Million)

6.1 Key trends, by application
6.2 Cardiovascular
- 6.2.1 Implantable cardiac defibrillators
- 6.2.2 Pacemakers
- 6.2.3 Stents
- 6.2.4 Vascular grafts
- 6.2.5 Sensors
- 6.2.6 Guidewires
- 6.2.7 Other cardiovascular applications
6.3 Ophthalmology
- 6.3.1 Contact lens
- 6.3.2 Intraocular lens
- 6.3.3 Ocular tissue replacement
- 6.3.4 Synthetic corneas
- 6.3.5 Other ophthalmic applications
6.4 Dental
- 6.4.1 Dental implants
- 6.4.2 Tissue regeneration materials
- 6.4.3 Bone grafts & substitutes
- 6.4.4 Dental membranes
- 6.4.5 Other dental applications
6.5 Orthopedic
- 6.5.1 Joint replacement biomaterials
- 6.5.2 Orthobiologics
- 6.5.3 Bioresorbable tissue fixation products
- 6.5.4 Visco supplementation
- 6.5.5 Spine biomaterials
- 6.5.6 Other orthopedic applications
6.6 Wound healing
- 6.6.1 Fracture healing device
- 6.6.2 Adhesion barrier
- 6.6.3 Skin substitutes
- 6.6.4 Internal tissue sealant
- 6.6.5 Surgical hemostats
- 6.6.6 Other wound healing applications
6.7 Plastic surgery
- 6.7.1 Soft tissue fillers
- 6.7.2 Facial wrinkle treatment
- 6.7.3 Craniofacial surgery
- 6.7.4 Bioengineered skins
- 6.7.5 Peripheral nerve repair
- 6.7.6 Acellular dermal matrices
- 6.7.7 Other plastic surgery applications
6.8 Neurology
- 6.8.1 Neural stem cell encapsulation
- 6.8.2 Shunting systems
- 6.8.3 Hydrogel scaffold for CNS repair
- 6.8.4 Cortical neural prosthetics
- 6.8.5 Other neurology applications
6.9 Tissue engineering
6.10 Other applications

Chapter 7 Biomaterials Market Size and Forecast, By Region, 2018 - 2032 (USD Million)

7.1 Key trends, by region
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Rest of Latin America
7.6 Middle East & Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 Rest of Middle East & Africa